Surrozen, Inc./DE — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research | Award / Grant | 1,666 | $8.11 | $13,511 | 14,709 | Dec 15, 2025 |
| Williams Charles O | Chief Operating Officer | Award / Grant | 1,666 | $8.11 | $13,511 | 11,048 | Dec 15, 2025 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 1,553 | $8.11 | $12,595 | 8,577 | Dec 15, 2025 |
| Kutzkey Tim | — | Purchase | 14,503 | $19.54 | $283,389 | 869,460 | Dec 5, 2025 |
| COLUMN GROUP III GP, LP | — | Purchase | 16,381 | $19.54 | $320,085 | 981,890 | Dec 4, 2025 |
| Kutzkey Tim | — | Purchase | 148,150 | $12.65 | $1,874,098 | 852,482 | Nov 13, 2025 |
| COLUMN GROUP III GP, LP | — | Purchase | 148,150 | $12.65 | $1,874,098 | 852,482 | Nov 13, 2025 |
| Li Yang | Exec. Vice President, Research | Award / Grant | 400 | $8.06 | $3,224 | 13,043 | Jun 13, 2025 |
| Williams Charles O | CFO and COO | Award / Grant | 400 | $8.06 | $3,224 | 9,382 | Jun 13, 2025 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 400 | $8.06 | $3,224 | 7,024 | Jun 13, 2025 |
| Column Group Opportunity III, LP | — | Purchase | 323,886 | $11.60 | $3,757,078 | 704,332 | Mar 26, 2025 |
| Li Yang | Exec. Vice President, Research | Option Exercise | 2,500 | — | — | 14,188 | Jan 3, 2025 |
| Williams Charles O | CFO and COO | Sale | 1,181 | $17.37 | $20,514 | 8,982 | Jan 2, 2025 |
| Li Yang | Exec. Vice President, Research | Award / Grant | 400 | $5.67 | $2,268 | 10,888 | Jun 14, 2024 |
| Williams Charles O | CFO and COO | Award / Grant | 400 | $5.67 | $2,268 | 5,863 | Jun 14, 2024 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 400 | $5.67 | $2,268 | 5,824 | Jun 14, 2024 |
| COLUMN GROUP III-A, LP | — | Purchase | 102,651 | $15.50 | $1,591,091 | 326,992 | Apr 4, 2024 |
| Kutzkey Tim | — | Purchase | 102,651 | $15.50 | $1,591,091 | 326,992 | Apr 4, 2024 |
| Williams Charles O | CFO and COO | Purchase | 1,474 | — | — | 1,474 | Apr 4, 2024 |
| Parker Craig C | Chief Executive Officer | Purchase | 1,474 | — | — | 1,474 | Apr 4, 2024 |
| Kutzkey Tim | — | Purchase | 90,897 | $15.50 | $1,408,904 | 294,767 | Apr 4, 2024 |
| COLUMN GROUP III GP, LP | — | Purchase | 90,897 | $15.50 | $1,408,904 | 294,767 | Apr 4, 2024 |
| Williams Charles O | Chief Financial Officer | Award / Grant | 2,085 | $5.67 | $11,822 | 2,085 | Dec 15, 2023 |
| Li Yang | Exec. Vice President, Research | Award / Grant | 2,085 | $5.67 | $11,822 | 2,085 | Dec 15, 2023 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 2,046 | $5.67 | $11,601 | 2,046 | Dec 15, 2023 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 25,000 | $0.38 | $9,500 | 34,578 | Jun 15, 2023 |
| Yeh Wen-Chen | Chief Scientific Officer | Award / Grant | 17,638 | $0.38 | $6,702 | 27,216 | Jun 15, 2023 |
| Williams Charles O | Chief Financial Officer | Award / Grant | 25,000 | $0.38 | $9,500 | 34,578 | Jun 15, 2023 |
| Yeh Wen-Chen | Chief Scientific Officer | Award / Grant | 9,578 | $0.41 | $3,927 | 229,138 | Dec 15, 2022 |
| Parker Craig C | Chief Executive Officer | Award / Grant | 9,578 | $0.41 | $3,927 | 9,578 | Dec 15, 2022 |
| Vanhove Geertrui | Chief Medical Officer | Award / Grant | 9,578 | $0.41 | $3,927 | 32,412 | Dec 15, 2022 |
| Williams Charles O | Chief Financial Officer | Award / Grant | 9,578 | $0.41 | $3,927 | 9,578 | Dec 15, 2022 |
| Soffer Benny | — | Sale | 1,297,922 | — | — | — | Dec 14, 2022 |
| Consonance Life Sciences | — | Award / Grant | 1,451,000 | — | — | 1,885,000 | Aug 11, 2021 |
| Jarrett Jennifer | — | Award / Grant | 30,000 | — | — | 30,000 | Aug 11, 2021 |
| Santel Donald J | — | Award / Grant | 30,000 | — | — | 30,000 | Aug 11, 2021 |
| Haqq Christopher | — | Award / Grant | 30,000 | — | — | 30,000 | Aug 11, 2021 |
| Soffer Benny | — | Disposition | 1,451,000 | — | — | — | Aug 11, 2021 |
| Livingston Kevin Harold | — | Disposition | 434,000 | — | — | — | Aug 11, 2021 |
| Consonance Capman GP, LLC | — | Disposition | 500,000 | — | — | — | Aug 11, 2021 |
| Livingston Kevin Harold | Chief Financial Officer | Purchase | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Soffer Benny | — | Award / Grant | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Consonance Life Sciences | — | Award / Grant | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Livingston Kevin Harold | Chief Financial Officer | Award / Grant | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| BLUTT MITCHELL J MD | — | Award / Grant | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| BLUTT MITCHELL J MD | — | Purchase | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Consonance Life Sciences | — | Purchase | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Soffer Benny | — | Purchase | 24,000 | — | — | 434,000 | Dec 1, 2020 |
| Soffer Benny | — | Purchase | 410,000 | — | — | 410,000 | Nov 23, 2020 |
| Consonance Life Sciences | — | Purchase | 410,000 | — | — | 410,000 | Nov 23, 2020 |